PROTAGONIST THERAPEUTICS INC (PTGX) Stock Institutional Owners
PROTAGONIST THERAPEUTICS INC (PTGX) is held by 2 institutional investors with a total value of $2.49M. This comprehensive analysis highlights the top institutional holders led by Polen Capital Management, Renaissance Technologies LLC, and others, who collectively account for nearly 100% of the total institutional ownership.Polen Capital Management remains the largest institutional holder with a position worth $1.78M. Explore insights into ownership patterns, position sizes, and portfolio allocations to understand institutional investment strategies and market sentiment.
Explore more:
- PROTAGONIST THERAPEUTICS INC (PTGX) stock institutional trading activity
- PROTAGONIST THERAPEUTICS INC (PTGX) stock insider trading activity
- Stock rankings
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance |
|---|---|---|---|---|
| Polen Capital Management | David M. Polen | 0.01% | 20,349 | $1,777,282 |
| Renaissance Technologies LLC | Jim Simons | 0.00% | 8,167 | $713,306 |
Frequently asked questions about PTGX
Who owns the most PTGX stock?
The largest holders of PTGX are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for PROTAGONIST THERAPEUTICS INC (PTGX).
Is PTGX widely held by superinvestors?
Many widely followed stocks like PTGX appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly PTGX is represented among the institutional managers we track.